Larimar Therapeutics (LRMR) Current Assets: 2013-2020
Historic Current Assets for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $107.8 million.
- Larimar Therapeutics' Current Assets rose 29.21% to $107.8 million in Q3 2020 from the same period last year, while for Sep 2020 it was $107.8 million, marking a year-over-year increase of 29.21%. This contributed to the annual value of $4.8 million for FY2019, which is 96.09% down from last year.
- Latest data reveals that Larimar Therapeutics reported Current Assets of $107.8 million as of Q3 2020, which was down 9.48% from $119.1 million recorded in Q2 2020.
- Larimar Therapeutics' Current Assets' 5-year high stood at $168.8 million during Q1 2016, with a 5-year trough of $4.8 million in Q4 2019.
- In the last 3 years, Larimar Therapeutics' Current Assets had a median value of $94.0 million in 2019 and averaged $91.2 million.
- As far as peak fluctuations go, Larimar Therapeutics' Current Assets skyrocketed by 37.44% in 2018, and later crashed by 96.09% in 2019.
- Quarterly analysis of 5 years shows Larimar Therapeutics' Current Assets stood at $130.9 million in 2016, then declined by 19.84% to $104.9 million in 2017, then climbed by 15.63% to $121.3 million in 2018, then plummeted by 96.09% to $4.8 million in 2019, then climbed by 29.21% to $107.8 million in 2020.
- Its last three reported values are $107.8 million in Q3 2020, $119.1 million for Q2 2020, and $64.7 million during Q1 2020.